Moreover, in BC, the treatment with cyclopamine, a known Hedgehog pathway inhibitor, increases the infiltration of M2-TAMs that, in turn, can limit the efficacy of chemotherapy by secreting Interleukin-6 (IL-6) (62). This evidence concerns the gene IL6 and breast cancer.